NEWS

Tenpoint Therapeutics™ is a clinical stage biopharmaceutical company launching a new era in presbyopia treatment and developing an innovative pipeline targeting the largest areas of unmet need for rejuvenating vision in the aging eye.

INVESTOR RELATIONS EVENTS

August 12–13, 2025
Canaccord Genuity 45th Annual Growth Conference: Link to Webcast Replay
‍
July 29, 2025
JonesTrading Virtual Presbyopia Panel, Throw The Reading Glass?: Link to Webcast‍

Press Releases

September 8, 2025

Tenpoint Therapeutics, Ltd. to Participate in Upcoming Eye Care Conferences

Tenpoint Therapeutics, Ltd. to Participate in Upcoming Eye Care Conferences

August 25, 2025

Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September

Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September

August 4, 2025

Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August

Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August

July 22, 2025

Tenpoint Therapeutics Ltd. to Participate in Virtual Presbyopia Panel Hosted by JonesTrading

Tenpoint Therapeutics Ltd. to Participate in Virtual Presbyopia Panel Hosted by JonesTrading

NEWS

March 11, 2025

With AbbVie in its sights, Tenpoint names commercial chief ahead of vision drug launch

January 9, 2025

10s for Tenpoint: Biotech preps for '26 market launch after phase 3 win for combo eye drop

November 1, 2022

What to Know About New Topical Presbyopia-Correcting Drops